Metoo- kampanjen har vist at bedrifter og organisasjoner har mangler i sine varslingsrutiner, hvordan varslene skal følges opp, og hvordan den skyldige eventuelt kan sies opp...
Tirsdag 5. juni 2018 – Hvordan kan vi dra nytte av den praktiske erfaringen med gjennomføring av personvernforordningen i året som har gått? TBD Pris for deltagere som er medlem...
Additive of substances other than vitamins and minerals in food supplements is not specifically regulated in the EU. Many countries have therefore developed national rules on su...
Since 2015, there has been an EU requirement that websites and apps selling medicines shall have a visible logo to show for legitimate and authorised operations. As from April 2...
Suppliers of medicines that take responsibility for environmentally friendly production, will now be rewarded by gaining an advantage in public tenders in Norway. Sykehusinnkjøp...
Celltrion and Sandoz have raised invalidity proceedings against Biogen's Norwegian patent on the use of rituximab in a particular treatment regimen for low-grade follicular B-ce...
Newsletter 1/2018 Life Sciences and Healthcare 1. Clinical trials: Biogen's rituximab patent found invalid due to a clinical trial started before the priority date Celltrion and...
“Market sources admit themselves tremendously impressed with the quality of the firm’s work” Chambers
